Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06029309
Title Zanubrutinib and Tafasitamab in Mantle Cell Lymphoma (ZANU-TAFA)
Acronym ZANU-TAFA
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Alvaro Alencar, MD
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.